Systemic THrombolysis Randomization IN Endovascular Stroke Therapy (SHRINE) Collaboration: a patient-level pooled analysis of the SKIP and DEVT Trials.
Raul Gomes NogueiraKazumi KimuraYuji MatsumaruKentaro SuzukiZhong Ming QiuWenjie ZiTimothy P MoranFengli LiHongfei SangWeidong LuoShuai LiuJunjie YuanJiaxing SongJiacheng HuangMasataka TakeuchiMasafumi MorimotoToshiaki OtsukaQingwu YangPublished in: Journal of neurointerventional surgery (2023)
The cumulative data of these two recent Asian trials failed to unequivocally demonstrate the non-inferiority of EVT alone over combined IVT+EVT. However, our study suggests a potential role for more individualized decision-making. Specifically, Asian patients with stroke onset to EVT longer than 180 min, as well as those with intracranial ICA occlusions and those with atrial fibrillation might have better outcomes with EVT alone than with combined IVT+EVT.
Keyphrases
- atrial fibrillation
- decision making
- oral anticoagulants
- left atrial
- catheter ablation
- heart failure
- left atrial appendage
- pulmonary embolism
- clinical trial
- case report
- type diabetes
- open label
- bone marrow
- stem cells
- phase iii
- glycemic control
- skeletal muscle
- mitral valve
- acute coronary syndrome
- replacement therapy
- optic nerve